HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Hongo Selected Research

Messenger RNA (mRNA)

3/2012Effects of N-[N-(3, 5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells.
7/2005Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer.
12/2004SSX expression in gynecological cancers and antibody response in patients.
12/2003Heparanase messenger RNA expression in epithelial ovarian tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Hongo Research Topics

Disease

22Neoplasms (Cancer)
11/2020 - 02/2003
16Endometrial Neoplasms (Endometrial Cancer)
01/2013 - 12/2004
11Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2012 - 12/2004
7Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 11/2003
5Neoplasm Metastasis (Metastasis)
02/2013 - 12/2003
5Lymphatic Metastasis
05/2009 - 07/2005
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2021 - 02/2002
4Ovarian Epithelial Carcinoma
01/2019 - 12/2003
4Endometrial Hyperplasia
05/2012 - 01/2008
3Adenocarcinoma
04/2010 - 02/2002
2Carcinoma (Carcinomatosis)
01/2019 - 01/2013
1Breast Neoplasms (Breast Cancer)
05/2020
1Hemorrhage
01/2019
1Fistula
01/2019
1Wounds and Injuries (Trauma)
01/2019
1Lymphedema (Milroy Disease)
10/2017
1Brain Neoplasms (Brain Tumor)
02/2013
1Struma Ovarii
01/2013
1Venous Thromboembolism
01/2013
1Adenocarcinoma in Situ
02/2012
1Obesity
07/2011
1Body Weight (Weight, Body)
07/2011
1Neutropenia
10/2010
1Necrosis
09/2010
1Leiomyosarcoma
09/2010
1Chronic Kidney Failure (Chronic Renal Failure)
05/2010
1Clear Cell Adenocarcinoma
04/2010
1Infections
08/2008
1Endometrioid Carcinoma
01/2008
1Testicular Neoplasms (Testicular Cancer)
12/2004

Drug/Important Bio-Agent (IBA)

10Biological ProductsIBA
05/2012 - 05/2008
5Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 02/2003
5Carboplatin (JM8)FDA LinkGeneric
01/2019 - 02/2003
5hepsinIBA
09/2010 - 02/2006
4Messenger RNA (mRNA)IBA
03/2012 - 12/2003
4HGF activatorIBA
06/2011 - 02/2009
3Indicators and Reagents (Reagents)IBA
01/2013 - 08/2009
3Tumor Biomarkers (Tumor Markers)IBA
02/2012 - 10/2011
3pirarubicinIBA
10/2010 - 02/2003
3matriptaseIBA
09/2010 - 02/2009
3Proteins (Proteins, Gene)FDA Link
08/2008 - 01/2008
2Bevacizumab (Avastin)FDA Link
05/2020 - 01/2019
2Cadherins (E-Cadherin)IBA
05/2012 - 06/2011
2VimentinIBA
05/2012 - 06/2011
2Serine Proteases (Serine Protease)IBA
05/2009 - 01/2008
2heparanaseIBA
07/2005 - 12/2003
2Heparitin Sulfate (Heparan Sulfate)IBA
07/2005 - 12/2003
2DNA (Deoxyribonucleic Acid)IBA
03/2002 - 02/2002
1Pharmaceutical PreparationsIBA
11/2020
1eribulinFDA Link
05/2020
1olaparibIBA
05/2020
1Vinorelbine (Navelbine)FDA LinkGeneric
05/2020
1PlatinumIBA
01/2019
1taxaneIBA
01/2019
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2017
1fibrin fragment D (D-dimer)IBA
01/2013
1ThyroglobulinFDA Link
01/2013
1Hemoglobins (Hemoglobin)IBA
01/2013
1FibrinIBA
11/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2012
1Small Interfering RNA (siRNA)IBA
05/2012
1Epidermal Growth Factor (EGF)IBA
05/2012
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
05/2012
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
03/2012
1EstersIBA
03/2012
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
03/2012
1C-Reactive ProteinIBA
01/2012
1CholesterolIBA
07/2011
1AnthracyclinesIBA
10/2010
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2010
1squamous cell carcinoma-related antigenIBA
10/2010
1Proteoglycans (Proteoglycan)IBA
04/2010
1Syndecan-1 (Syndecan 1)IBA
04/2010
1Versicans (Versican)IBA
04/2010
1Fetal Proteins (Fetoprotein)IBA
03/2010
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2010
1Glucose (Dextrose)FDA LinkGeneric
01/2010
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
08/2008
1Secretory Leukocyte Peptidase InhibitorIBA
05/2008
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2007
1Etoposide (VP 16)FDA LinkGeneric
03/2007
1Cisplatin (Platino)FDA LinkGeneric
03/2007
1Epirubicin (Ellence)FDA LinkGeneric
03/2007
1AgarIBA
02/2006
1ThymidineIBA
07/2005
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
07/2005
1AntibodiesIBA
12/2004

Therapy/Procedure

6Drug Therapy (Chemotherapy)
01/2019 - 02/2003
5Therapeutics
11/2020 - 06/2007
4Radiotherapy
02/2013 - 09/2008
4Hysterectomy
12/2012 - 03/2002
4Lymph Node Excision (Lymph Node Dissection)
09/2011 - 03/2002
2Combination Drug Therapy (Combination Chemotherapy)
10/2010 - 05/2010
1Brachytherapy
02/2021
1Transplantation
11/2020
1Laparotomy
01/2013
1Perioperative Period
11/2012
1Chemoradiotherapy
02/2012
1Renal Dialysis (Hemodialysis)
05/2010
1Adjuvant Chemotherapy
03/2007